3. Results A number of 795 patients were recorded in the Saiful Anwar
General Hospital ACS registry in between 2018-2021 with 568 subjects
were enrolled in the study. Between selected subjects, 387 patients had
received early PPCI, 107 patients had received late PPCI, while 74
patients had received optimal medical therapy, i.e. did not receive PPCI
and/or fibrinolytic. Percentage comparison between each category was
shown in Figure 3.1.
The data showed significant reduction in the percentage of
patients receiving early PPCI during 4 years timeframe, with 73.8%
patients received early PPCI in 2018 and 56.8% patients received early
PPCI in 2021. On the contrary, patients receiving late PPCI has substan-
tially increased from 15.9% in 2018 and 30.7% in 2021 with significant
rise occurred in the last two years. Patients receiving optimal medical
therapy however, have been relatively steady in the past 4 years.
3.1 Baseline Characteristic Comparison The percentage of subjects represented in baseline character-
istics such as gender, age, and body weight was proportionally distrib-
uted in between each category. Significant results regarding onset
within each category was also demonstrated (P=0.01). There were also
no significant difference in between the percentage of cardiovascular
risk factors i.e. smoking, diabetes, hypertension, dyslipidemia, family
history of CAD, etc. within each category as shown in table 3.1. Howev-
er, the proportion of patients presenting with KILLIP Class IV was
substantially higher within optimal medical therapy category compared
with late and early PPCI group (P=0.049). This result was also consis-
tent with higher GRACE score (P=0.001) and Troponin I levels
(P=0.043) in patients receiving optimal medical therapy. While other
baseline parameters were evenly measured in between each category.
Figure 3.1 Comparison of patients in each category from 2018-2021
A. S. Santoso, et al.
Heart Sci J 2022; 3(2): 10-17
12
Table 3.2 Baseline characteristics of subjects in each category